Frequency Analysis of Coronary Artery Disease
A Single-centered Investigation Into the Frequency Domain Patterns in Vessels of Patients With Coronary Artery Disease
1 other identifier
observational
330
1 country
1
Brief Summary
The purpose of this study is to determine if coronary artery disease can be detected using an electronic, acoustic recording instrument. The presence or absence of abnormal pathology will be confirmed by diagnostic angiography as part of the normal patient care at this institution.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2009
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2009
CompletedFirst Submitted
Initial submission to the registry
January 4, 2010
CompletedFirst Posted
Study publicly available on registry
January 6, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2013
CompletedSeptember 5, 2014
September 1, 2014
4 years
January 4, 2010
September 3, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
to determine if coronary artery disease can be detected using an electronic, acoustic recording instrument
to determine if coronary artery disease can be detected using an electronic, acoustic recording instrument
Baselin
Eligibility Criteria
Patients presenting to the University of Minnesota Medical Center (UMMC) Fairview Clinics, Physicians (UMP) or the Redwing, Minnesota clinic
You may qualify if:
- Patients aged 18-89 years old and recommended for a cardiology related angiogram within 24 hours
You may not qualify if:
- Any patient less than 18 years of age or greater than 89 years of age.
- Any patient with any of the following conditions: pregnant or nursing, prior myocardial infarction, left ventricular device, heart transplant, valve replacement, congestive heart failure, atrial fibrillation (non-intermittent), endocarditis or any heart viral or bacterial infection, any patient who has or requires medication or other heart rhythm altering treatment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Minnesota Medical Center (UMMC) Fairview Clinics
Minneapolis, Minnesota, 55455, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Robert Wilson, MD
University of Minnesota
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 4, 2010
First Posted
January 6, 2010
Study Start
March 1, 2009
Primary Completion
March 1, 2013
Study Completion
March 1, 2013
Last Updated
September 5, 2014
Record last verified: 2014-09